3-129532420-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000539.3(RHO):​c.696+4C>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0847 in 1,613,784 control chromosomes in the GnomAD database, including 6,274 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.078 ( 525 hom., cov: 32)
Exomes 𝑓: 0.085 ( 5749 hom. )

Consequence

RHO
NM_000539.3 splice_region, intron

Scores

2
Splicing: ADA: 0.00009567
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -5.24

Publications

8 publications found
Variant links:
Genes affected
RHO (HGNC:10012): (rhodopsin) The protein encoded by this gene is found in rod cells in the back of the eye and is essential for vision in low-light conditions. The encoded protein binds to 11-cis retinal and is activated when light hits the retinal molecule. Defects in this gene are a cause of congenital stationary night blindness. [provided by RefSeq, Aug 2017]
RHO Gene-Disease associations (from GenCC):
  • congenital stationary night blindness autosomal dominant 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • retinitis pigmentosa 4
    Inheritance: AD, AR, SD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • congenital stationary night blindness
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • retinitis pigmentosa
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • fundus albipunctatus
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 3-129532420-C-T is Benign according to our data. Variant chr3-129532420-C-T is described in ClinVar as Benign. ClinVar VariationId is 256384.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.101 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RHONM_000539.3 linkc.696+4C>T splice_region_variant, intron_variant Intron 3 of 4 ENST00000296271.4 NP_000530.1 P08100

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RHOENST00000296271.4 linkc.696+4C>T splice_region_variant, intron_variant Intron 3 of 4 1 NM_000539.3 ENSP00000296271.3 P08100

Frequencies

GnomAD3 genomes
AF:
0.0780
AC:
11858
AN:
151988
Hom.:
524
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0698
Gnomad AMI
AF:
0.0307
Gnomad AMR
AF:
0.0802
Gnomad ASJ
AF:
0.161
Gnomad EAS
AF:
0.0639
Gnomad SAS
AF:
0.108
Gnomad FIN
AF:
0.0374
Gnomad MID
AF:
0.0949
Gnomad NFE
AF:
0.0836
Gnomad OTH
AF:
0.0946
GnomAD2 exomes
AF:
0.0815
AC:
20448
AN:
250880
AF XY:
0.0854
show subpopulations
Gnomad AFR exome
AF:
0.0716
Gnomad AMR exome
AF:
0.0600
Gnomad ASJ exome
AF:
0.163
Gnomad EAS exome
AF:
0.0634
Gnomad FIN exome
AF:
0.0360
Gnomad NFE exome
AF:
0.0837
Gnomad OTH exome
AF:
0.101
GnomAD4 exome
AF:
0.0854
AC:
124825
AN:
1461678
Hom.:
5749
Cov.:
34
AF XY:
0.0873
AC XY:
63481
AN XY:
727136
show subpopulations
African (AFR)
AF:
0.0691
AC:
2315
AN:
33480
American (AMR)
AF:
0.0621
AC:
2777
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.163
AC:
4267
AN:
26136
East Asian (EAS)
AF:
0.0510
AC:
2025
AN:
39700
South Asian (SAS)
AF:
0.118
AC:
10151
AN:
86258
European-Finnish (FIN)
AF:
0.0379
AC:
2018
AN:
53266
Middle Eastern (MID)
AF:
0.128
AC:
736
AN:
5768
European-Non Finnish (NFE)
AF:
0.0853
AC:
94889
AN:
1111962
Other (OTH)
AF:
0.0935
AC:
5647
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
7118
14235
21353
28470
35588
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3572
7144
10716
14288
17860
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0781
AC:
11874
AN:
152106
Hom.:
525
Cov.:
32
AF XY:
0.0776
AC XY:
5770
AN XY:
74370
show subpopulations
African (AFR)
AF:
0.0700
AC:
2905
AN:
41500
American (AMR)
AF:
0.0801
AC:
1225
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.161
AC:
560
AN:
3468
East Asian (EAS)
AF:
0.0635
AC:
327
AN:
5152
South Asian (SAS)
AF:
0.108
AC:
522
AN:
4822
European-Finnish (FIN)
AF:
0.0374
AC:
396
AN:
10590
Middle Eastern (MID)
AF:
0.0918
AC:
27
AN:
294
European-Non Finnish (NFE)
AF:
0.0836
AC:
5682
AN:
67968
Other (OTH)
AF:
0.0956
AC:
202
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
553
1105
1658
2210
2763
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
134
268
402
536
670
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0839
Hom.:
396
Bravo
AF:
0.0802
Asia WGS
AF:
0.106
AC:
372
AN:
3478
EpiCase
AF:
0.0953
EpiControl
AF:
0.0969

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Pigmentary retinal dystrophy Benign:1
Nov 07, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Retinitis pigmentosa 4 Benign:1
Nov 07, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Congenital stationary night blindness autosomal dominant 1 Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Retinitis pigmentosa Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.0020
DANN
Benign
0.64
PhyloP100
-5.2
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000096
dbscSNV1_RF
Benign
0.0020
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs56340615; hg19: chr3-129251263; COSMIC: COSV56214717; API